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Abstract: Injectable filling agents offer the promise of a better appearance without surgery 
and, among them, hyaluronic acid is the most commonly used. Although complications are 
rare, it is necessary to know the possible side effects and complications in order to be prepared 
for their management. That is why many researchers have been focusing on the interactions 
between hyaluronic acid and pathogens, inflammatory mediators, the immune system, and 
markers of oxidative stress to achieve efficient drug delivery, given that hyaluronic acid has 
widening applications in the field of nanomedicine. Here we report the case of a 37-year-old 
female patient who returned to our clinic with an abscess in her left cheek 3 months after a deep 
injection of 1 mL of stabilized hyaluronic acid in both cheeks. Steroid and antibiotic therapy 
was initiated without success, and abscess drainage was performed. Extraction of tooth 16 was 
performed 11 days after insertion of drains into the abscess. Laboratory blood tests showed 
acute inflammation of presumed bacterial etiology. Microbiological examination of pus was 
 negative. Bacterial cultures were found in the extracted tooth. After antibiotic therapy, a com-
plete reversal of the pathological process was observed. The present report highlights the need 
to assess periodontal problems prior to any aesthetic facial treatment. Analyses of further case 
reports and clinical studies are necessary to understand the potential role of hyaluronic acid in 
the  formation of biofilm, and how to avoid this complication, thereby increasing the safety of 
hyaluronic acid-based procedures.
Keywords: pantomogram, biofilm, hyaluronic acid, fluorescent in situ hybridization, peptide 
nucleic acids
Introduction
For a lot of patients who are seeking facial rejuvenation, injectable filling agents 
show great promise to improve somebody’s appearance without surgery. According 
to the American Society of Aesthetic Plastic Surgery, it has been recently reported 
that more than 5 million procedures have been performed using cosmetic injectable 
compounds, and more than 85% of all dermal filler procedures have been based on a 
hyaluronic acid-derived filler.1 Hyaluronic acid is a nonsulfated, naturally occurring 
glycosaminoglycan with a structure consisting of alternately repeating D-glucuronic 
acid and N-acetylglucosamine units found in several tissues, with the highest con-
centration occurring in humans in the extracellular matrix of soft connective tissue.2 
In the hands of experienced physicians, hyaluronic acid can be safely used as a filler, 
although complications, such as bruising and necrosis, may occur and need to be man-
aged promptly.3,4 Although the procedures can be generally considered simple and safe, 
it is important that, because of the widespread clinical use of hyaluronic acid-based 
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fillers, physicians performing these procedures consider the 
possible consequences and are prepared for their  management.5 
For example, prior to facial rejuvenation procedures, no den-
tal pantomograms are performed. Further, even if the risk of 
bacterial biofilm development on the injected filling agent 
and virulence are rare, these potential complications must be 
taken into consideration.6 This report describes a rare case of 
bacterial biofilm formation on hyaluronic acid filler deeply 
injected into the cheeks, probably spread from improper 
endodontic treatment of tooth 16 (first molar).
Hyaluronic acid and nanomedicine
Hyaluronic acid has been extensively studied in relation to 
markers of inflammation, oxidative stress, and immune sys-
tem because it has applications not only in aesthetic medicine, 
but also in other clinical fields, including ophthalmology, 
traumatology, urology, and nanomedicine.7 Especially with 
regard to the latter, hyaluronic acid has been used for drug 
delivery and therefore it has become of key importance to 
understand its relationship to pathogens and to study its 
effect on inflammatory mediators, the immune system, and 
markers of oxidative stress. For instance, hyaluronic acid has 
been used to transport chemotherapeutic drugs.8 It has been 
shown to be useful when administered intraperitoneally for 
improving the effects of paclitaxel in gastric cancer.9 Further-
more, an experimental study of hyaluronic acid-conjugated 
butyric acid has showed rapid cellular uptake in a human 
breast carcinoma cell line.10 Another example of the use of 
hyaluronic acid, to target cells and tissues delivering peptides, 
comes from a study using hybrid nanoparticles containing 
hyaluronic acid and iron oxide which showed high efficiency 
due to highly specific targeting of CD44, a hyaluronic acid 
binding receptor found on the surface of tumor cells and 
inflammatory cells.11 In the field of ocular drug delivery, 
hyaluronic acid has been used to modify chitosan nanopar-
ticles, indicating that it might enhance their mucoadhesive-
ness and efficiency.12
With regard to the effect of hyaluronic acid on inflam-
matory mediators, immune cells, and oxidative stress, it has 
been observed that hyaluronic acid produces a low-grade 
inflammatory response when it stimulates peripheral blood 
mononuclear cells.13 The same study also showed a slight 
increase in the production of interferon-γ and higher expres-
sion of CD25, CD69, and CD71 in phytohemagglutinin-
stimulated peripheral blood mononuclear cells from patients 
who underwent hyaluronic acid filler injections and displayed 
adverse effects.
As far as oxidative stress is concerned, another study 
investigated the role of chitotriosidase, YKL-40 (a member 
of the chitinase-like proteins), and myeloperoxidase in 
inflammatory adverse reactions related to dermal fillers 
in 169 users in order to understand their relationship 
with the development of clinical symptoms.14 This study 
showed: (1) a significant rise in circulating myeloperoxi-
dase protein levels associated with more severe adverse 
reactions in dermal filler users in the absence of infection 
which was linked to an increased inflammatory interaction, 
augmented adhesion of circulating leukocytes to vascular 
endothelial cells and endothelial dysfunction; (2) elevated 
plasma chitotriosidase activity in the majority of dermal 
filler users, particularly those with adverse reactions, 
underscoring a greater activity of monocytes/macrophages 
in these patients; (3) an increase in plasma YKL-40 
expression in dermal filler users with or without clinical 
adverse reactions; (4) a significant increase in plasma 
fluorescent lipid peroxidation products (an indirect mea-
surement of macromolecular peroxidation) in dermal filler 
users with and without adverse reactions; (5) a significant 
increase in concentrations of advanced oxidation protein 
products (a marker of oxidative damage to proteins) that 
were similarly increased in filler users with and without 
adverse reactions, as compared with controls.14
With regard to the relationship between hyaluronic acid 
and pathogens, we have recently reported an analysis of the 
interactions between hyaluronic acid and viruses, bacteria, 
and fungal species. For instance, hyaluronic acid inhibits 
coxsackievirus B5 (COXB5), mumps virus (MV) and 
influenza virus strain WSN33 (A/H1N1), herpes simplex 
virus type 1 and porcine parvovirus (PPV), while it exerts 
no activity against adenovirus-5 (ADV-5), human herpes 
virus-6 (HHV-6), and porcine reproductive and respiratory 
syndrome virus (PRRSV).15 In terms of bacterial and 
fungal  species, staphylococci, enterococci, Streptococcus 
mutans, two Escherichia coli strains, Pseudomonas aerugi-
nosa,  Candida glabrata, and Candida parapsilosis exhibit 
hyaluronic acid dose-dependent growth inhibition, while 
E. coli ATCC 13768 and Candida albicans do not exhibit 
any effect, and Streptococcus sanguinis is favored by 
high hyaluronic acid dose.16 In summary, hyaluronic acid 
produces changes in the immune system, inflammatory 
mediators, and markers of oxidative stress, and may interact 
with pathogens. This evidence should be taken into account 
when performing hyaluronic acid-based delivery of drugs 
and medical procedures in clinical practice.
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Case report
A 37-year-old woman required correction of flattened cheeks 
as a result of aging. After discussing a variety of treatment 
options with the patient, we decided to utilize an injectable 
deep subdermal hyaluronic acid filler. The patient signed 
her informed consent. The procedure was performed at our 
aesthetic clinic (Academy of Face Sculpturing,  Warsaw, 
Poland). The patient was in excellent health and her 
endodontic condition was good, as assessed by objective 
examination. No chronic diseases were reported, and she 
did not report taking any medicines. The patient had had 
an orthodontic appliance installed several months prior to 
the procedure without any reported problems. A lidocaine-
prilocaine anesthetic cream was applied to the external cheek 
area prior to the procedure. Her skin was disinfected accord-
ing to surgical standards. A total of 1 mL of hyaluronic acid 
(Restylane® SubQ; Q-Med, Poland) was injected into each 
cheek via a 23-gauge needle introduced at the apex of the 
zygomatic arch directed towards her orbicularis oculi and 
zygomaticus muscles. Treatment also included administra-
tion of 1 mL of hyaluronic acid (Restylane; Q-Med) into both 
her nasolabial folds and 1 mL of hyaluronic acid  (Restylane 
Lipp; Q-Med) into her lips in the area of the vermillion 
border and orbicularis oris muscles in order to improve their 
appearance. The patient tolerated the procedure well and was 
satisfied with the results. She was advised to call the clinic 
if any problem occurred.
Three months later, the patient returned to the clinic 
because of a firm swelling, approximately 2 cm in diameter, 
in the area of the left zygomatic arch. Antibiotic therapy was 
started (clindamycin 300 mg, four times per day) along with 
prednisone (Encorton® 20 mg, once a day). Three weeks of 
treatment failed to produce an improvement in the patient’s 
condition. The inflammatory process caused an increase 
in swelling, resulting in accumulation of an unknown fluid 
which was mobile and ballotable with increased tension in 
her skin (Figure 1). Laboratory blood tests (Table 1) showed 
results consistent with acute inflammation of bacterial 
etiology, and no signs of an allergic reaction were present 
(Table 1). Intraoral incision and drainage of a cheek abscess 
was performed, with intraoral drains placed to allow drain-
age of abundant purulent discharge. The pus was sent for 
microbiological tests (with clinical material analysis and 
microbiological identification of aerobic bacteria, anaerobic 
bacteria, and yeast-like fungi performed in accordance with 
standard laboratory procedures recommended by the Clinical 
Figure 1 Swelling resulting from accumulation of fluid within the skin.
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Figure 2 Possible spreading of the bacterial process from improper endodontic treatment of tooth 16.
Table 1 Patient’s clinical profile
Test Result Clinical reference
White blood cells 13.1 4–11 109/L
Neutrophils 82.8 50%–66%
Lymphocytes 12.6 20%–40%
Eosinophils 0.7 0%–7%
CRP 11,5 ,10 mg/L
SD 11 ,12 mm/hour
IgM 103 40–240 mg/dL
IgG 1039 700–1600 mg/dL
IgE (Total) 19.6 0–120 IU/mL
Total protein 7.8 6.2–8.2 g/dL
TSH 0.432 0.27–4.2 μLU/mL
Free T4 15.4 12–22 pmol/L
Free T3 5.2 3.1–6.8 pmol/L
Fibrinogen 488 200–400 mg/dL
D-dimers 807 0–500 ng/mL
Anti-streptolysin O ,200 ,200 IU/mL
Aspartate aminotransferase 25 5–40 U/L
Alanine aminotransferase 20 7–56 U/L
and Laboratory Standards Institute).  Biochemical identifi-
cation of microorganisms and antimicrobial  susceptibility 
tests were performed using the Vitek 2 system (BioMerieux, 
B asingstoke, Hampshire, UK). C omputerized tomography 
and dental pantomography (Kodak 9000 C 3D) were 
performed and indicated possible spreading of bacterial 
process from improper endodontic treatment of tooth 16 
(Figure 2). Antibiotic treatment was changed to amoxicillin 
875 mg and clavulanic acid 125 mg twice a day, along with 
metronidazole 500 mg three times a day. Microbiological tests 
for aerobic and anaerobic bacteria taken from pus yielded 
negative results. Extraction of tooth 16 was performed 
11 days after insertion of drains into the abscess. At the same 
time, a small aggregation of pus located in the same general 
area was incised and evacuated. Biochemical identification 
of microorganisms and antimicrobial susceptibility tests, 
performed using the Vitek 2 system, were also performed. 
Microbiological testing indicated the presence of strains of 
Enterococcus faecalis, Lactococcus lactis cremoris, and 
Streptococcus mitis. Extraction of the tooth that had caused 
the inflammatory infection, along with the evacuation of 
the abscess and concomitant antibiotic therapy, resulted in a 
complete reversal of the pathological process (Figure 3). Two 
months later, 2 mL of hyaluronic acid (Princess  Volume®, 
Leobendorf, Austria) was injected into the patient’s left 
cheek (Figure 4). She refused to use Q-Med products again. 
There were no further signs of infection. Biochemical results 
were within normal limits. No further complications were 
observed in the year following hyaluronic acid augmentation 
into her left cheek. The patient underwent a standard medical 
diagnostic procedure.
Discussion
According to the literature, hyaluronic acid-based filler  injections 
can be considered safe, but complications may develop as it 
has been previously reported. Biofilm is a  dangerous compli-
cation, especially with deeply placed  injections. This report 
highlights the need to carry out careful dental restoration before 
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Figure 3 Reversal of pathological process after tooth extraction, evacuation of abscess, and antibiotic therapy.
Figure 4 Patient’s appearance after injection of 2 mL of hyaluronic acid into her left cheek.
any aesthetic treatment of the face. It is likely that biofilm 
can form on all materials that are administered, despite the 
depth of injection. Since hyaluronic acid is retained within the 
body for only a short period of time because of the action of 
hyaluronidase (the tissue half-life of hyaluronic acid ranges 
from hours to days), the biofilm rapidly biodegrades along 
with hyaluronic acid.17 Therefore, this complication should 
be considered solely with extended-duration hyaluronic acid 
material. To avoid such complications in the future, a study of 
the nature of biofilm specifically created on hyaluronic acid 
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should be performed. The injection of fillers can increase the 
risk of bacterial infections because of improper or inadequate 
disinfection of the skin, presence of potential pathogens, such 
as the patients’ own microflora, eg, Propionibacterium acnes, 
Staphylococcus epidermidis, and mycobacteria, decreased 
immunity, and poor injection technique.
All implanted materials induce the normal body reaction 
to foreign compounds, but the strength of the reaction var-
ies.18 Macrophages, lymphocytes, plasma cells, and foreign 
body giant cells are usually found.19 Bacteria, introduced 
during hyaluronic acid implantation, can cause untoward 
reactions mainly attributable to bacterial biofilm formation. 
In the case of bacteria within biofilm, the resistance of these 
bacteria to antibiotics is 1000 times greater and treatment 
of untoward reactions requires a larger dose of antibiotics.18 
Side effects are quite rare, but occur 0.1%–0.5% of the time, 
 depending on the type of fillers utilized. These reactions can 
occur immediately, several weeks, months, or even years after 
injection of the  filler.19 In the present case, biofilm formation 
may have occurred. A “sterile abscess” that may have formed 
as part of a foreign body reaction caused by introduction of 
hyaluronic acid into the cheek or it may have resulted from 
an abscess of the infected tooth. Both types of complications 
are extremely rare in this type of aesthetic procedure. The 
first complication, ie, the “sterile abscess”, is highly unlikely 
even though negative bacterial cultures were obtained. 
Abscesses of this type have been reported after administration 
of hyaluronic acid in aesthetic procedures and in treatment 
of urinary stress incontinence.20–22 The reason for this reac-
tion is not known, but an allergic origin or a foreign body 
reaction can be hypothesized.23,24 Undoubtedly, the physi-
cochemical properties of the preparation and the  injection 
technique may have a decisive impact on the occurrence of 
such complications. With regard to hyaluronic acid, we must 
consider actual particle size, shape, hydrophobicity, degree 
of purification, depth and site of administration, and even 
the diameter of the needle.18,25 Allergies cannot be  triggered, 
because the hyaluronic acid currently in use is not of animal 
origin, but it is derived from bacteria. Furthermore, in our 
case, the abscess occurred unilaterally and hyaluronic acid 
preparation was administered in both cheeks.
Some researchers believe that reported cases of “sterile 
abscesses”, when dealing with a bacterial infection and sterile 
cultures, stem from the fact that bacteria can be found on the 
surface of a foreign body (in this case, the particles of the 
preparation) in the form of biofilm. Within the liquid mass of 
the abscess there can be so few bacteria that they are virtu-
ally undetectable by conventional microbiological method.26 
A sensitive method for the detection of bacteria is known 
as fluorescent in situ hybridization which utilizes universal 
probes, such as peptide nucleic acids and fluorochrome-
labelled specific DNA sequences found in all bacteria and 
specific only to bacteria. Common bacteria forming biofilms 
are not potentially pathogenic and the presence of biofilm 
does not produce acute symptoms; it can be slow and asymp-
tomatic for months or years, and may activate and exacerbate 
only in special cases, such as an injury.
The second possibility is that our case was one of  maxillary 
osteomyelitis. In patients without filling  material, a cheek 
abscess is usually an odontogenic infection. In our patient, 
this possibility, exists primarily because of the  pantogram 
indicating an inflammatory process in the region of the tooth. 
However, the negative cultures tend to negate this possibility 
even if the patient had received clindamycin prior to the collec-
tion of cultures, and this could explain the negative test results. 
The causes of periodontal infection are mainly anaerobic 
flora, and clindamycin is particularly active against anaerobes. 
From the small reservoir of pus under the tooth, E. faecalis 
was cultivated, along with other microorganisms. E. faecalis 
can cause inflammation,  especially in combination with other 
microorganisms, and is intrinsically resistant to clindamycin 
used in empirical therapy and could be responsible for biofilm 
and further abscess formation. The infectious nature of this 
abscess was indicated by test results showing elevated levels 
of  leukocytes,  neutrophils, D-dimers, and fibrinogen. With the 
available test results, it is difficult to determine the primary 
cause of the described complications. Most likely it was a 
tooth that was not completely restored to a healthy state endo-
dontically. However, it is quite possible that the cheek abscess 
would not have formed if the filler had not been injected. The 
filler acted as a substrate for bacterial biofilm formation which 
favored the development of the abscess. It is worth mentioning 
that the filler was injected into both cheeks, but the problem 
appeared only on the side of the infected tooth. In order to 
better diagnose this type of complication better, there should 
have been microbiological samples of the purulent matter prior 
to administration of any antibiotics. In addition, a biopsy with 
histopathological analysis would have been a valuable test. 
Subsequently, one could attempt biomolecular testing, even 
if beyond routine analytical procedures.
We want to emphasize that the present case report, based 
on the present diagnostic medical standard, did not prevent 
biofilm development. Therefore, we propose the introduction 
of fluorescent in situ hybridization into clinical practice when 
we are facing a probable biofilm-related infection due to 
its high reliability. This procedure would allow us to detect 
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biofilm and start antibiotic therapy promptly, allowing its 
immediate resolution. Furthermore, based on the present case 
report, we suggest that a pantomogram, which is an easy and 
cost-effective test, should be performed before a cosmetic 
procedure involving a hyaluronic acid injection.
Due to the widespread use of hyaluronic acid, not only 
in aesthetic medicine, but also in an effort to achieve more 
efficient drug delivery, it is of vital importance to determine 
how biofilm may form when hyaluronic acid-based fillers 
are used. Therefore, it is important to analyze this and other 
case reports, as well as undertake larger clinical studies to 
determine if hyaluronic acid is involved in the formation of 
biofilm. It is also possible that, in the near future, studies 
focusing on changes in the hyaluronic acid molecule may help 
to limit the complications associated with hyaluronic acid 
injection, making hyaluronic acid-based procedures safer.
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